Salman Hussain is a panelist during the summit where he is discussing patient-focused drug development in alopecia areata.
For more information on this event, click here.
Evidence requirements for orphan drugs
CRA’s Life Sciences Practice focuses on global policy, commercialization, and market access issues dedicated to orphan drug issues, including orphan evidence...